美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件: 药品名称=GARAMYCIN
符合检索条件的记录共8
1 页 当前第 1 页  返回检索页
1药品名称GARAMYCIN
申请号050039产品号002
活性成分GENTAMICIN SULFATE市场状态停止上市
剂型或给药途径SOLUTION/DROPS;OPHTHALMIC规格EQ 0.3% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构SCHERING CORP SUB SCHERING PLOUGH CORP
2药品名称GARAMYCIN
申请号050425产品号001
活性成分GENTAMICIN SULFATE市场状态停止上市
剂型或给药途径OINTMENT;OPHTHALMIC规格EQ 0.3% BASE
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构SCHERING CORP SUB SCHERING PLOUGH CORP
3药品名称GARAMYCIN
申请号050505产品号001
活性成分GENTAMICIN SULFATE市场状态停止上市
剂型或给药途径INJECTABLE;INTRATHECAL规格EQ 2MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构SCHERING CORP SUB SCHERING PLOUGH CORP
4药品名称GARAMYCIN
申请号060462产品号001
活性成分GENTAMICIN SULFATE市场状态停止上市
剂型或给药途径CREAM;TOPICAL规格EQ 0.1% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构SCHERING CORP SUB SCHERING PLOUGH CORP
5药品名称GARAMYCIN
申请号060463产品号001
活性成分GENTAMICIN SULFATE市场状态停止上市
剂型或给药途径OINTMENT;TOPICAL规格EQ 0.1% BASE
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构SCHERING CORP SUB SCHERING PLOUGH CORP
6药品名称GARAMYCIN
申请号061716产品号001
活性成分GENTAMICIN SULFATE市场状态停止上市
剂型或给药途径INJECTABLE;INJECTION规格EQ 40MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构SCHERING CORP SUB SCHERING PLOUGH CORP
7药品名称GARAMYCIN
申请号061716产品号002
活性成分GENTAMICIN SULFATE市场状态停止上市
剂型或给药途径INJECTABLE;INJECTION规格EQ 1MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构SCHERING CORP SUB SCHERING PLOUGH CORP
8药品名称GARAMYCIN
申请号061739产品号001
活性成分GENTAMICIN SULFATE市场状态停止上市
剂型或给药途径INJECTABLE;INJECTION规格EQ 10MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构SCHERING CORP SUB SCHERING PLOUGH CORP